Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Arikian

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Therapeutics|May 24, 2000
A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) studyS Arikian
Pharmacoeconomics|November 7, 2000
Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United KingdomH Freeman, S Arikian, A Lenox-Smith
International Journal of Clinical Practice|July 17, 2001
The health economic impact of antidepressant usage from a payer's perspective: a multinational studyJ Casciano, J Doyle, S Arikian, et al.
Clinical Therapeutics|January 1, 1995
A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disordersT R Einarson, S Arikian, S Sweeney, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 1987
Low rectovaginal fistulasF Pepe, M Panella, S Arikian, et al.
Epidemiologia E Psichiatria Sociale|January 19, 2000
A pharmacoeconomic evaluation of major depressive disorder (Italy)J Casciano, S Arikian, J E Tarride, et al.
Pharmacoeconomics|March 8, 1996
Clinical and economic factors in the treatment of onychomycosisT R Einarson, A K Gupta, N H Shear, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Dermoid cysts of the ovaryF Pepe, M Panella, G Pepe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancerW McGuire, A I Neugut, S Arikian, et al.
Oncology (Williston Park, N.Y.)|February 12, 1998
A pharmacoeconomic comparison of UFT and 5-FU chemotherapy for colorectal cancer in South AmericaA Murad, C A de Andrade, C Delfino, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Therapeutics|May 24, 2000
A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) studyS Arikian
Pharmacoeconomics|November 7, 2000
Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United KingdomH Freeman, S Arikian, A Lenox-Smith
International Journal of Clinical Practice|July 17, 2001
The health economic impact of antidepressant usage from a payer's perspective: a multinational studyJ Casciano, J Doyle, S Arikian, et al.
Clinical Therapeutics|January 1, 1995
A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disordersT R Einarson, S Arikian, S Sweeney, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 1987
Low rectovaginal fistulasF Pepe, M Panella, S Arikian, et al.
Epidemiologia E Psichiatria Sociale|January 19, 2000
A pharmacoeconomic evaluation of major depressive disorder (Italy)J Casciano, S Arikian, J E Tarride, et al.
Pharmacoeconomics|March 8, 1996
Clinical and economic factors in the treatment of onychomycosisT R Einarson, A K Gupta, N H Shear, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Dermoid cysts of the ovaryF Pepe, M Panella, G Pepe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancerW McGuire, A I Neugut, S Arikian, et al.
Oncology (Williston Park, N.Y.)|February 12, 1998
A pharmacoeconomic comparison of UFT and 5-FU chemotherapy for colorectal cancer in South AmericaA Murad, C A de Andrade, C Delfino, et al.
Pageof 2